Vulvovaginal Candidiasis Treatment Market

Global Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Regional Outlook and Forecast, 2022 - 2028

Report Id: KBV-12601 Publication Date: November-2022 Number of Pages: 226
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Vulvovaginal Candidiasis Treatment Market, by Distribution Channel
1.4.2 Global Vulvovaginal Candidiasis Treatment Market, by Route of Administration
1.4.3 Global Vulvovaginal Candidiasis Treatment Market, by Drug Class
1.4.4 Global Vulvovaginal Candidiasis Treatment Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Vulvovaginal Candidiasis Treatment Market by Distribution Channel
3.1 Global Retail Pharmacy Market by Region
3.2 Global Hospital Pharmacy Market by Region
3.3 Global Online Pharmacy Market by Region

Chapter 4. Global Vulvovaginal Candidiasis Treatment Market by Route of Administration
4.1 Global Oral Market by Region
4.2 Global Intravenous Market by Region
4.3 Global Topical Market by Region

Chapter 5. Global Vulvovaginal Candidiasis Treatment Market by Drug Class
5.1 Global Fluconazole Market by Region
5.2 Global Clotrimazole Market by Region
5.3 Global Terconazole Market by Region
5.4 Global Terbinafine Market by Region
5.5 Global Nystatin Market by Region
5.6 Global Ketoconazole Market by Region
5.7 Global Others Market by Region

Chapter 6. Global Vulvovaginal Candidiasis Treatment Market by Region
6.1 North America Vulvovaginal Candidiasis Treatment Market
6.1.1 North America Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.1.1.1 North America Retail Pharmacy Market by Country
6.1.1.2 North America Hospital Pharmacy Market by Country
6.1.1.3 North America Online Pharmacy Market by Country
6.1.2 North America Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.1.2.1 North America Oral Market by Country
6.1.2.2 North America Intravenous Market by Country
6.1.2.3 North America Topical Market by Country
6.1.3 North America Vulvovaginal Candidiasis Treatment Market by Drug Class
6.1.3.1 North America Fluconazole Market by Country
6.1.3.2 North America Clotrimazole Market by Country
6.1.3.3 North America Terconazole Market by Country
6.1.3.4 North America Terbinafine Market by Country
6.1.3.5 North America Nystatin Market by Country
6.1.3.6 North America Ketoconazole Market by Country
6.1.3.7 North America Others Market by Country
6.1.4 North America Vulvovaginal Candidiasis Treatment Market by Country
6.1.4.1 US Vulvovaginal Candidiasis Treatment Market
6.1.4.1.1 US Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.1.4.1.2 US Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.1.4.1.3 US Vulvovaginal Candidiasis Treatment Market by Drug Class
6.1.4.2 Canada Vulvovaginal Candidiasis Treatment Market
6.1.4.2.1 Canada Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.1.4.2.2 Canada Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.1.4.2.3 Canada Vulvovaginal Candidiasis Treatment Market by Drug Class
6.1.4.3 Mexico Vulvovaginal Candidiasis Treatment Market
6.1.4.3.1 Mexico Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.1.4.3.2 Mexico Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.1.4.3.3 Mexico Vulvovaginal Candidiasis Treatment Market by Drug Class
6.1.4.4 Rest of North America Vulvovaginal Candidiasis Treatment Market
6.1.4.4.1 Rest of North America Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.1.4.4.2 Rest of North America Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.1.4.4.3 Rest of North America Vulvovaginal Candidiasis Treatment Market by Drug Class
6.2 Europe Vulvovaginal Candidiasis Treatment Market
6.2.1 Europe Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.2.1.1 Europe Retail Pharmacy Market by Country
6.2.1.2 Europe Hospital Pharmacy Market by Country
6.2.1.3 Europe Online Pharmacy Market by Country
6.2.2 Europe Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.2.2.1 Europe Oral Market by Country
6.2.2.2 Europe Intravenous Market by Country
6.2.2.3 Europe Topical Market by Country
6.2.3 Europe Vulvovaginal Candidiasis Treatment Market by Drug Class
6.2.3.1 Europe Fluconazole Market by Country
6.2.3.2 Europe Clotrimazole Market by Country
6.2.3.3 Europe Terconazole Market by Country
6.2.3.4 Europe Terbinafine Market by Country
6.2.3.5 Europe Nystatin Market by Country
6.2.3.6 Europe Ketoconazole Market by Country
6.2.3.7 Europe Others Market by Country
6.2.4 Europe Vulvovaginal Candidiasis Treatment Market by Country
6.2.4.1 Germany Vulvovaginal Candidiasis Treatment Market
6.2.4.1.1 Germany Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.2.4.1.2 Germany Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.2.4.1.3 Germany Vulvovaginal Candidiasis Treatment Market by Drug Class
6.2.4.2 UK Vulvovaginal Candidiasis Treatment Market
6.2.4.2.1 UK Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.2.4.2.2 UK Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.2.4.2.3 UK Vulvovaginal Candidiasis Treatment Market by Drug Class
6.2.4.3 France Vulvovaginal Candidiasis Treatment Market
6.2.4.3.1 France Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.2.4.3.2 France Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.2.4.3.3 France Vulvovaginal Candidiasis Treatment Market by Drug Class
6.2.4.4 Russia Vulvovaginal Candidiasis Treatment Market
6.2.4.4.1 Russia Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.2.4.4.2 Russia Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.2.4.4.3 Russia Vulvovaginal Candidiasis Treatment Market by Drug Class
6.2.4.5 Spain Vulvovaginal Candidiasis Treatment Market
6.2.4.5.1 Spain Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.2.4.5.2 Spain Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.2.4.5.3 Spain Vulvovaginal Candidiasis Treatment Market by Drug Class
6.2.4.6 Italy Vulvovaginal Candidiasis Treatment Market
6.2.4.6.1 Italy Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.2.4.6.2 Italy Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.2.4.6.3 Italy Vulvovaginal Candidiasis Treatment Market by Drug Class
6.2.4.7 Rest of Europe Vulvovaginal Candidiasis Treatment Market
6.2.4.7.1 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.2.4.7.2 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.2.4.7.3 Rest of Europe Vulvovaginal Candidiasis Treatment Market by Drug Class
6.3 Asia Pacific Vulvovaginal Candidiasis Treatment Market
6.3.1 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.3.1.1 Asia Pacific Retail Pharmacy Market by Country
6.3.1.2 Asia Pacific Hospital Pharmacy Market by Country
6.3.1.3 Asia Pacific Online Pharmacy Market by Country
6.3.2 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.3.2.1 Asia Pacific Oral Market by Country
6.3.2.2 Asia Pacific Intravenous Market by Country
6.3.2.3 Asia Pacific Topical Market by Country
6.3.3 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class
6.3.3.1 Asia Pacific Fluconazole Market by Country
6.3.3.2 Asia Pacific Clotrimazole Market by Country
6.3.3.3 Asia Pacific Terconazole Market by Country
6.3.3.4 Asia Pacific Terbinafine Market by Country
6.3.3.5 Asia Pacific Nystatin Market by Country
6.3.3.6 Asia Pacific Ketoconazole Market by Country
6.3.3.7 Asia Pacific Others Market by Country
6.3.4 Asia Pacific Vulvovaginal Candidiasis Treatment Market by Country
6.3.4.1 China Vulvovaginal Candidiasis Treatment Market
6.3.4.1.1 China Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.3.4.1.2 China Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.3.4.1.3 China Vulvovaginal Candidiasis Treatment Market by Drug Class
6.3.4.2 Japan Vulvovaginal Candidiasis Treatment Market
6.3.4.2.1 Japan Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.3.4.2.2 Japan Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.3.4.2.3 Japan Vulvovaginal Candidiasis Treatment Market by Drug Class
6.3.4.3 India Vulvovaginal Candidiasis Treatment Market
6.3.4.3.1 India Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.3.4.3.2 India Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.3.4.3.3 India Vulvovaginal Candidiasis Treatment Market by Drug Class
6.3.4.4 South Korea Vulvovaginal Candidiasis Treatment Market
6.3.4.4.1 South Korea Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.3.4.4.2 South Korea Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.3.4.4.3 South Korea Vulvovaginal Candidiasis Treatment Market by Drug Class
6.3.4.5 Singapore Vulvovaginal Candidiasis Treatment Market
6.3.4.5.1 Singapore Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.3.4.5.2 Singapore Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.3.4.5.3 Singapore Vulvovaginal Candidiasis Treatment Market by Drug Class
6.3.4.6 Malaysia Vulvovaginal Candidiasis Treatment Market
6.3.4.6.1 Malaysia Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.3.4.6.2 Malaysia Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.3.4.6.3 Malaysia Vulvovaginal Candidiasis Treatment Market by Drug Class
6.3.4.7 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market
6.3.4.7.1 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.3.4.7.2 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.3.4.7.3 Rest of Asia Pacific Vulvovaginal Candidiasis Treatment Market by Drug Class
6.4 LAMEA Vulvovaginal Candidiasis Treatment Market
6.4.1 LAMEA Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.4.1.1 LAMEA Retail Pharmacy Market by Country
6.4.1.2 LAMEA Hospital Pharmacy Market by Country
6.4.1.3 LAMEA Online Pharmacy Market by Country
6.4.2 LAMEA Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.4.2.1 LAMEA Oral Market by Country
6.4.2.2 LAMEA Intravenous Market by Country
6.4.2.3 LAMEA Topical Market by Country
6.4.3 LAMEA Vulvovaginal Candidiasis Treatment Market by Drug Class
6.4.3.1 LAMEA Fluconazole Market by Country
6.4.3.2 LAMEA Clotrimazole Market by Country
6.4.3.3 LAMEA Terconazole Market by Country
6.4.3.4 LAMEA Terbinafine Market by Country
6.4.3.5 LAMEA Nystatin Market by Country
6.4.3.6 LAMEA Ketoconazole Market by Country
6.4.3.7 LAMEA Others Market by Country
6.4.4 LAMEA Vulvovaginal Candidiasis Treatment Market by Country
6.4.4.1 Brazil Vulvovaginal Candidiasis Treatment Market
6.4.4.1.1 Brazil Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.4.4.1.2 Brazil Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.4.4.1.3 Brazil Vulvovaginal Candidiasis Treatment Market by Drug Class
6.4.4.2 Argentina Vulvovaginal Candidiasis Treatment Market
6.4.4.2.1 Argentina Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.4.4.2.2 Argentina Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.4.4.2.3 Argentina Vulvovaginal Candidiasis Treatment Market by Drug Class
6.4.4.3 UAE Vulvovaginal Candidiasis Treatment Market
6.4.4.3.1 UAE Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.4.4.3.2 UAE Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.4.4.3.3 UAE Vulvovaginal Candidiasis Treatment Market by Drug Class
6.4.4.4 Saudi Arabia Vulvovaginal Candidiasis Treatment Market
6.4.4.4.1 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.4.4.4.2 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.4.4.4.3 Saudi Arabia Vulvovaginal Candidiasis Treatment Market by Drug Class
6.4.4.5 South Africa Vulvovaginal Candidiasis Treatment Market
6.4.4.5.1 South Africa Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.4.4.5.2 South Africa Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.4.4.5.3 South Africa Vulvovaginal Candidiasis Treatment Market by Drug Class
6.4.4.6 Nigeria Vulvovaginal Candidiasis Treatment Market
6.4.4.6.1 Nigeria Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.4.4.6.2 Nigeria Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.4.4.6.3 Nigeria Vulvovaginal Candidiasis Treatment Market by Drug Class
6.4.4.7 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market
6.4.4.7.1 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Distribution Channel
6.4.4.7.2 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Route of Administration
6.4.4.7.3 Rest of LAMEA Vulvovaginal Candidiasis Treatment Market by Drug Class

Chapter 7. Company Profiles
7.1 Bayer AG
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Pfizer, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional & Segmental Analysis
7.2.4 Research & Development Expense
7.3 Bristol Myers Squibb Company
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Astellas Pharma, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.5 Mycovia Pharmaceuticals, Inc. (NovaQuest Capital Management, LLC)
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Trials and Approvals:
7.6 Basilea Pharmaceutica Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Scynexis, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Research & Development Expenses
7.7.4 Recent strategies and developments:
7.7.4.1 Trials and Approvals:
7.8 Grupo Ferrer Internacional S.A.
7.8.1 Company Overview
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo